Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Start my free visit Illustration only not the actual vial
doi: 10.1016/s0167-5273(02)00237-1
Pathway 2: Glucagon-Receptor-Mediated Hepatic Effects Glucagon receptor activation increases hepatic glucose production and upregulates cytochrome P450 activity, particularly CYP3A4 and CYP2C9
Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
US$ 21.39
US$ 22.92
US$ 22.31
US$ 28.31
US$ 23.99
US$ 21.44
